ALTMAN MICHAEL SETH

CIK 00017467388 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001746738

Recent Transactions

23 trades

Conversion
Freenome, Inc.$FRNM
Common Stock
2026-07-20+2,066,250→ 2,352,500 total
Conversion
Freenome, Inc.$FRNM
Class B Ordinary Shares
2026-07-20−2,066,250→ 0 total
Disposition to Issuer
ARYA Sciences Acquisition Corp IV
Class B ordinary shares
2024-07-31−2,647,500→ 0 total
Disposition to Issuer
ARYA Sciences Acquisition Corp IV
Class B ordinary shares
2024-07-31−1,000,000→ 2,647,500 total
Disposition to Issuer
ARYA Sciences Acquisition Corp IV
Class A ordinary shares
2024-07-31−499,000→ 0 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2024-06-14+45,000→ 45,000 total
Award
Freenome, Inc.$FRNM
Class A ordinary shares
2024-06-13$10.00/sh+286,250→ 286,250 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2024-06-13+30,000→ 30,000 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2023-06-30+20,000→ 20,000 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2023-06-15+45,000→ 45,000 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2022-06-16+7,250→ 7,250 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 total
Award
ARYA Sciences Acquisition Corp V
Class A ordinary shares
2021-07-15$10.00/sh+499,000→ 499,000 total
Conversion
Nautilus Biotechnology, Inc.$NAUT
Class B ordinary shares
2021-06-09−3,647,500→ 0 total
Conversion
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-06-09+3,647,500→ 3,647,500 total
Conversion
Nautilus Biotechnology, Inc.$NAUT
Class A ordinary shares
2021-06-09−499,000→ 0 total
Conversion
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-06-09+499,000→ 499,000 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to buy)
2021-06-09+44,435→ 44,435 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2021-05-26+7,250→ 7,250 total
Award
ARYA Sciences Acquisition Corp IV
Class A ordinary shares
2021-03-02$10.00/sh+499,000→ 499,000 total
Other
Nautilus Biotechnology, Inc.$NAUT
Class A ordinary shares
2020-08-11$10.00/sh+499,000→ 499,000 total
Other
Cerevel Therapeutics Holdings, Inc.
Class A ordinary shares
2020-06-09$10.00/sh+499,000→ 499,000 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2020-04-30+14,500→ 14,500 total

Companies

Recent Filings

Address

C/O PERCEPTIVE CAPITAL SOLUTIONS HOLDING 51 ASTOR PLACE, 10TH FLOOR

NEW YORK, NY, 10003

View on SEC.gov